About Alpenglow Biosciences
Alpenglow Biosciences is a Healthcare company based in Seattle (United States) founded in 2014. 3D visualization software for tissue image analysis is provided. Alpenglow Biosciences has raised $6.38 million across 6 funding rounds from investors including HHS and Dynamk Capital. Its chief executive, as recorded, is Nicholas Reder. Alpenglow Biosciences offers products and services including Aurora 3D Spatial Biology Solution and 3D Assay Service. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis. Its competitors include PathAI, Deepcell and Pictor Labs; 3 of its 3 listed competitors have raised funding.
Company details
Alpenglow Biosciences was founded in 2014 in Seattle, United States. Software solutions for 3D visualization of biological images are developed and supplied. AI-assisted tools are utilized by researchers to examine complex morphological structures within tissue samples. Operations are centered in the biotechnology sector, with services aimed at enhancing image analysis for scientific applications. The companys domain is alpenglowbiosciences.com.
- Headquarters Seattle, United States
- SectorsHealthcare
- Email••••••••
- Website alpenglowbiosciences.com
- Social LinkedIn X
- Annual Revenue$96.53 K (USD)as on Jul 31, 2023
- Net Profit$68.89 K (USD)as on Jul 31, 2023
- Total Equity Funding$6.38M (USD)
in 6 rounds
- Latest Funding Round$1.8M (USD), Series A
Mar 2024
- InvestorsHHS
& 1 more
Products & Services of Alpenglow Biosciences
Alpenglow Biosciences offers a comprehensive portfolio of products and services, including Aurora 3D Spatial Biology Solution and 3D Assay Service.
Platform for 3D tissue imaging and AI analysis in medical research
Service for advanced tissue analysis in dermatology and oncology applications
Funding Insights of Alpenglow Biosciences
Alpenglow Biosciences has successfully raised a total of $6.38M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $1.8 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.38M
- Total Rounds 6
- Last Round Series A — $1.8M
- First Round $1.39M
(Sep 2020)
- Investors Count 2
All 6 funding rounds of Alpenglow Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $1.8M | Series A | – | – | – |
| Apr 2022 | $252,516 | Grant | – | – | |
| Sep 2021 | $269,314 | Grant | – | – | |
| Jul 2021 | $398,302 | Grant | – | – | |
| Jun 2021 | $4.58M | Series A | – | Dynamk Capital | – |
| Sep 2020 | $1.39M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Alpenglow Biosciences
Alpenglow Biosciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and Dynamk Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in life sciences innovation is facilitated by Dynamk Capital. | dynamk.vc | New York, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Alpenglow Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Alpenglow Biosciences
10 people are tracked at Alpenglow Biosciences (4 in leadership, 2 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Nicholas Reder | CEO | Leadership |
Alex Springer | Chief Of Staff | Leadership |
Elisa Barbieri | Director Of Marketing And Business Development | Leadership |
Caleb Stoltzfus | Director of Research and Development | Leadership |
Adam Glaser | Co-Founder | Board & advisors |
Jonathan Liu | Co-Founder | Board & advisors |
Steve Pemberton | SVP, Commercial Development | Team |
Luis Restrepo | Research And Development Scientist | Team |
Jasmine Wilson | Senior Principal Data Scientist | Team |
David Simmons | Algorithm Engineer | Team |
Complete people profiles for Alpenglow Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Alpenglow Biosciences
3 dated milestones of Alpenglow Biosciences across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Alpenglow Biosciences is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Series A, of $1.8M.
Competitors of Alpenglow Biosciences
Alpenglow Biosciences has 3 listed competitors in our database, 3 of them funded. They include PathAI, Deepcell and Pictor Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathai.com | 2016 | Boston, United States | $254.94M | 573 | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | |
| deepcell.com | 2015 | Mountain View, United States | $122.99M | 94 | AI-powered single cell classification and isolation technology for clinical research | |
| pictorlabs.ai | 2019 | Los Angeles, United States | $48.83M | AI-based tools for pathological image analysis are provided to labs. |
Detailed competitors of Alpenglow Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Alpenglow Biosciences
The website of Alpenglow Biosciences (alpenglowbiosciences.com) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 73.9% vs previous month
Websites whose visitors overlap most with Alpenglow Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cyrusbio.com | 100% | 1.9K | #9,105,938 | View details | |
| talus.bio | 100% | 4.4K | #4,306,649 | View details | |
| omeros.com | 99% | 15.6K | #1,695,799 | View details | |
| soundpharma.com | 98% | 2.7K | #5,693,412 | View details | |
| rarecyte.com | 97% | 3.2K | #5,681,690 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Alpenglow Biosciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Alpenglow Biosciences (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Alpenglow Biosciences
Complete news archive for Alpenglow Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alpenglow Biosciences
Alpenglow Biosciences was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Alpenglow Biosciences is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Nicholas Reder is the CEO of Alpenglow Biosciences, as recorded in our data.
Alpenglow Biosciences is a funded company, having raised a total of $6.38M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.39M, raised on Sep 2020.
Annual revenue of Alpenglow Biosciences is $96.53K as on Jul 31, 2023.
Alpenglow Biosciences was founded in 2014 in Seattle, United States. Software solutions for 3D visualization of biological images are developed and supplied. AI-assisted tools are utilized by researchers to examine complex morphological structures within tissue samples. Operations are centered in the biotechnology sector, with services aimed at enhancing image analysis for scientific applications. The companys domain is alpenglowbiosciences.com.
Alpenglow Biosciences's top competitors include Pictor Labs, PathAI and Deepcell.
Alpenglow Biosciences offers Aurora 3D Spatial Biology Solution and 3D Assay Service.
Alpenglow Biosciences has 2 investors. Key investors include HHS, and Dynamk Capital.